Incruse Ellipta vs. Breo Ellipta
Are Incruse Ellipta and Breo Ellipta the Same Thing?
Incruse Ellipta (umeclidinium) Inhalation Powder and Breo Ellipta (fluticasone furoate and vilanterol) are used for maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Breo Ellipta is also used to reduce exacerbations (sudden worsening) of COPD in patients with a history of exacerbations.
Incruse Ellipta and Breo Ellipta belong to different drug classes. Incruse Ellipta is an anticholinergic drug and Breo Ellipta is a combination inhaled corticosteroid and long-acting beta2-adrenergic agonists (LABA).
Side effects of Incruse Ellipta and Breo Ellipta that are similar include upper respiratory infection, stuffy or runny nose, cough, sore throat, and joint pain.
Side effects of Incruse Ellipta that are different from Breo Ellipta include muscle pain, tooth pain, stomach pain, bruising or dark areas of skin, chest pain, fast or irregular heartbeat, and constipation.
Side effects of Breo Ellipta that are different from Incruse Ellipta include headache, oral candidiasis (thrush in your mouth or throat), back pain, pneumonia, bronchitis, sinus infection, mouth pain, influenza, and fever.
Incruse Ellipta may interact with other anticholinergic drugs.
Breo Ellipta may interact with antifungal medications containing ketoconazole, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, and diuretics.
What Are Possible Side Effects of Incruse Ellipta?
Common side effects of Incruse Ellipta include:
- upper respiratory infection,
- stuffy or runny nose,
- cough,
- sore throat,
- joint pain,
- muscle pain,
- tooth pain,
- stomach pain,
- bruising or dark areas of skin,
- chest pain,
- fast or irregular heartbeat, and
- constipation.
What Are Possible Side Effects of Breo Ellipta?
Common side effects of Breo Ellipta include:
- upper respiratory tract infection,
- runny nose,
- sore throat,
- headache,
- oral candidiasis (thrush in your mouth or throat),
- back pain,
- pneumonia,
- bronchitis,
- sinus infection,
- cough,
- mouth pain,
- joint pain,
- influenza,
- sore throat, and
- fever.
What Is Incruse Ellipta?
Incruse Ellipta (umeclidinium) Inhalation Powder is an anticholinergic drug used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
What Is Breo Ellipta?
Breo Ellipta (fluticasone furoate and vilanterol) is a combination inhaled corticosteroid (ICS) and long-acting beta2-adrenergic agonists (LABA) used to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Breo Ellipta is also used to reduce exacerbations (sudden worsening) of COPD in patients with a history of exacerbations.
What Drugs Interact With Incruse Ellipta?
Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Incruse Ellipta should be taken only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
What Drugs Interact With Breo Ellipta?
Breo Ellipta may interact with antifungal medications containing ketoconazole, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, or diuretics.
How Should Incruse Ellipta be Taken?
Incruse Ellipta (umeclidinium 62.5 mcg) should be administered as 1 inhalation dose once daily by the orally inhaled route only. Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use.
How Should Breo Ellipta be Taken?
Breo Ellipta is dosed as 100 mcg/25 mcg once daily. Breo Ellipta is a dry powder for oral inhalation only. Patients with allergies to milk or milk proteins and patients with sensitivities to any component of Breo Ellipta should not use it.